Printer Friendly

CUSTOMEDIX REPORTS RESULTS

 CUSTOMEDIX REPORTS RESULTS
 OLDWICK, N.J., Aug. 26 /PRNewswire/ -- Customedix Corporation


(AMEX: CUS; Boston Stock Exchange: CUSB), a health care products company, today released the company's operating results for the 1992 fiscal year and fiscal 1992s fourth quarter.
 For fiscal 1992, Customedix incurred a net loss of $1,541,648, or 45 cents per share, versus a net profit of $843,367, or 26 cents per share, for fiscal 1991. Net income from continuing operations was $651,858, or 19 cents per share, for fiscal 1992 versus $1,230,420, or 38 cents per share, for fiscal 1992 versus $1,230,420, or 38 cents per share, for fiscal 1991. Sales for the year were $36,866,465 versus $36,295,382 for fiscal 1991, an increase of 1.6 percent.
 For the fourth quarter of fiscal 1992, net income was $308,159, or 8 cents per share, versus net income of $211,089, or 6 cents per share, for the fourth quarter of fiscal 1991. Net income from continuing operations was $308,159, or 8 cents per share, versus $252,031, or 8 cents per share, for the comparable quarter in 1991. Sales for the quarter were $9,758,829 versus $9,331,123 for last year.
 The company's subsidiary, Automatic Injection Molding, Inc. was discontinued as of Dec. 31, 1991 and the results of its operations have been excluded from the company's continuing operations and shown as discontinued operation.
 CUSTOMEDIX CORPORATION
 Condensed Consolidated Statements of Operations
 Quarter ended Fiscal year ended
 6/30/92 6/30/91 6/30/92 6/30/91
 Sales $9,758,829 $9,331,123 $36,866,465 $36,295,382
 Income from cont.
 operations before
 income taxes 327,657 268,770 842,858 1,314,420
 Income taxes (A) 19,498 16,739 191,000 84,000
 Income from cont.
 operations 308,159 252,031 651,858 1,230,420
 Loss on discont.
 operation (C) -- (40,942) (2,193,506) (387,053)
 Net income (loss) 308,159 211,089 (1,541,648) 843,367
 Income per share from
 cont. operations .08 .08 .19 .38
 Net income (loss) per
 share .08 .06 (.45) .26
 Weighted average shares
 outstanding (B) 3,735,749 3,260,840 3,431,370 3,279,623
 CONDENSED CONSOLIDATED BALANCE SHEET 6/30/92 6/30/91
 Assets
 Cash and cash equivalents $ 745,457 $ 684,495
 Receivables 5,863,934 6,331,197
 Inventory 5,526,166 5,663,415
 Assets of discontinued operation 62,929 --
 Other 230,535 602,758
 Total current assets 12,429,021 13,281,865
 Property and equipment, net 2,958,500 5,041,903
 Other 6,732,726 7,324,307
 Total assets 22,120,247 25,648,075
 Liabilities
 Payables and accrued expenses 3,341,785 3,469,218
 Accrued expenses for disposal of operation 602,320 --
 Current maturities of long-term debt and
 capital lease obligations 737,110 829,644
 Total current liabilities 4,681,215 4,298,862
 Long-term debt and capital lease obligations 9,050,162 12,011,921
 Other -- 108,571
 Total liabilities 13,731,377 16,419,354
 Stockholders' equity:
 Common stock and additional paid-in capital 27,500,986 26,799,189
 Accumulated deficit (19,112,116)(17,570,468)
 Total stockholders' equity 8,388,870 9,228,721
 Total liabilities and stockholders' equity $22,120,247 $25,648,075
 (A) Taxes on income represent certain minimum federal and state income taxes and are less than the statutory rate due primarily to the availability of net loss carryforwards.
 (B) On Nov. 4, 1991, the shareholders voted to decrease the number of shares outstanding by effecting a one-for-ten reverse split of common stock. This action was given retroactive effect for all periods presented.
 (C) The company's subsidiary, Automatic Injection Molding, Inc., was discontinued as of Dec. 31, 1991 and the result of its operations have been excluded from the company's continuing operations for the periods presented.
 -0- 8/26/92
 /CONTACT: Andrew A. Miller, CFO, 908-439-2226, or Joe MacDougald director of Investor Relations, both of Customedix Corporation/ 203-265-7397/
 (CUS) CO: Customedix Corporation ST: New Jersey IN: HEA SU: ERN


PS-KW -- NY033 -- 3468 08/26/92 12:36 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 26, 1992
Words:699
Previous Article:KRAFT USA ANNOUNCES PLANS FOR CHEESE PRODUCTION AT FORMER LOUIS RICH FACILITY IN TULARE
Next Article:PERKIN-ELMER INCREASES FOURTH QUARTER EARNINGS BY 55 PERCENT; FISCAL YEAR 1992 INSTRUMENTS ORDERS, SALES, INCOME AT RECORD LEVELS
Topics:


Related Articles
CUSTOMEDIX REPORTS FIRST QUARTER FINANCIAL RESULTS
CUSTOMEDIX SHAREHOLDERS APPROVE REVERSE STOCK SPLIT
CUSTOMEDIX SUBSIDIARY'S LARGEST CUSTOMER TO CEASE ORDERS
CUSTOMEDIX REPORTS RESULTS
CUSTOMEDIX REPORTS RESULTS
CUSTOMEDIX CORP. REPORTS FINANCIAL RESULTS FOR ITS THIRD QUARTER AND NINE MONTHS OF FISCAL 1995
CUSTOMEDIX CORP. REPORTS FINANCIAL RESULTS FOR ITS FIRST QUARTER OF FISCAL 1996
CUSTOMEDIX CORP. REPORTS FINANCIAL RESULTS FOR ITS SECOND QUARTER AND SIX MONTHS OF FISCAL 1996
CUSTOMEDIX CORP. REPORTS FINANCIAL RESULTS FOR ITS THIRD QUARTER AND NINE MONTHS OF FISCAL 1996
Customedix Corporation Stockholders Approve Merger

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters